3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
1
Motor Activity
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Behavior
1
Interventions
Leucovorin
4
Fluorouracil
3
Oxaliplatin
2
Laparoscopy
2
Cetuximab
2
Capecitabine
2
tislelizumab
1
ferric maltol
1
envafolimab
1
Tranexamic Acid
1
Surgical Procedures, Operative
1
Ropivacaine
1
Propofol
1
Preoperative Exercise
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Nitrous Oxide
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Motivational Interviewing
1
Isoflurane
1
Irinotecan
1
Ipilimumab
1
Immunohistochemistry
1
HMPL-013
1
Folfox protocol
1
Filgrastim
1
Fentanyl
1
Epinephrine
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Colonic Neoplasms
×
Motivational Interviewing
×
Clear all
NCT03210129
2019-03-14
MIPAClux
Luxembourg Institute of Health
Phase NA
Completed
25 enrolled